Nobel for Sale
It seems that another pharmaceutical shill has influenced the decision to award Luc Montagnier this year’s Nobel Prize in Medicine.
Nobel Organization member and Professor, Jan Andersson, also has two direct conflicts of interest in his work with GlaxoSmithKline and at his company known as AVARIS.
The Swedish biotech company sprung from cell and gene therapy research at the Karolinska Institutet. Avaris develops therapies and vaccines that are ostensibly used to fight HIV and leukemia. The market for Avaris products is estimated to be worth $4.5 billion annually.
By awarding Luc Montagnier a Nobel Prize, Andersson gives unearned legitimacy to HIV and AIDS research that Andersson, his investors, and all HIV and AIDS companies, employees, and shareholders profit from directly.
This corroborates previous allegations that the Nobel Prize is for sale. Although previous awards have been presented to undeniably worthy recipients, today’s Nobel prizes appear to be not unlike the Hollywood Walk of Fame stars that are handed out to “Hollywood giants” when, in fact, they are given to anyone whose production or public relations company is willing to pony the fee (somewhere between $20,000 and $100,000) to the Hollywood Chamber of commerce. Presentations are usually coordinated with the promotion of an upcoming movie or television show.
Although the Nobel Prizes to Al Gore, Jimmy Carter and Yassar Arafat made it pretty clear that the award was already corrupted by politics, the fact that pharmaceutical companies can now openly buy awards for promotional reasons should indicate the state of medicine and science in the world.
That the pharmaceutical industry could buy the Nobel Committee makes Luc Montagnier another dead canary in the medical and scientific cave.